Simultaneous Quantitative Determination of Nine Hallucinogenic NBOMe Derivatives in Human Plasma Using Liquid Chromatography Tandem Mass Spectrometry

다국어 초록 (Multilingual Abstract)

We developed a bioanalytical method for simultaneous determination of nine NBOMe derivatives (25H-NBOMe, 25B-NBOMe, 25E-NBOMe, 25N-NBOMe, 25C-NBOH, 25I-NBOH, 25B-NBF, 25C-NBF, and 25I-NBF) in human plasma using liquid chromatography tandem mass spectrometry (LC-MS/MS). Human plasma samples were pre-treated using solid-phase extraction. Sepa-ration was achieved on a C18 column under gradient elution using a mobile phase containing 0.1% formic acid in acetonitrile and 0.1% formic acid in water at a flow rate of 0.3 mL/min. Mass detection was performed in the positive ion mode using multiple reaction moni-toring. The calibration range was 1-100ng/mL for all quantitative analytes, with a correlation coefficient greater than 0.99. The intra- and inter-day precision and accuracy varied from 0.85 to 6.92% and from 90.19 to 108.69%, respectively. The recovery ranged from 86.36 to 118.52%, and the matrix effects ranged from 27.09 to 99.72%. The stability was acceptable in various conditions. The LC-MS/MS method was validated for linearity, accuracy, precision, matrix effects, recovery and stability in accordance with the FDA guidance. The proposed method is suitable for reliable and robust routine screening and analysis of nine NBOMe derivatives in forensic field.

참고문헌 (Reference)

1 Corazza, O, 24 : 82-, 2013

2 Pichini, S, 76 : 2124-, 2004

3 Deluca, P, 39 : 221-, 2012

4 Chambers, E, 852 : 22-, 2007

5 Zhang, L, 955 : 10-, 2014

6 Berman, S, 1141 : 195-, 2008

7 Suzuki, J, 56 : 129-, 2015

8 Hansen M, 5 : 243-, 2014

9 Johnson, R. D, 38 : 479-, 2014

10 Poklis, J. L, 38 : 113-, 2014

11 da Cunha, K. F, 36 : 113-, 2018

12 Notari, S, 831 : 258-, 2006

13 Jung, B. H, 21 : 1095-, 2007

14 Bansal, S, 9 : E109-, 2007

15 Dadgar, D, 14 : 23-, 1995

16 United Nations Office on Drugs and Crime (UNODC), "World Drug Report 2017"

17 Food and Drug Administration (FDA), "Guidance for industry on bioanalytical method validation 2013"